TORONTO (PRWEB) April 09, 2020
COVIDCollaborators.org aims to connect service providers with researchers working on novel treatments and vaccines for COVID-19. Some of the services being offered include clinical research, clinical software, EDC, manufacturing, investigator training, patient recruitment, use of facilities, virtual services, and clinical trial management.
“The Zymewire team was looking for ways to help accelerate the timeline toward a treatment or vaccine,” said Pete Bastedo, CEO at Zymewire. “We realized that with direct relationships with the world’s leading drug development service companies, we were in a unique position to build something like this. By listing the services and expertise being offered by these companies in a centralized directory, our hope is that it gains the attention of drug developers around the globe, and that together, they can quickly bring new drugs to market.”
If your organization has expertise to contribute to the fight against COVID-19, or if you’re a researcher seeking assistance, Zymewire invites you to become a COVID Collaborator. There is no cost associated with listing or accessing offerings. For further information and to get involved, visit COVIDCollaborators.org.
Zymewire builds a digital sales research assistant that helps organizations understand what's happening in their industry, so they can uncover new opportunities to grow their business. The company’s initial industry focus is biotech and pharma, where over 300 pharmaceutical and biotechnology service providers around the world trust Zymewire for their sales research. Zymewire is committed to delivering industry awareness to an ever-increasing number of people, in whatever way helps them to make the most informed decisions, take the most immediate action and be the most awesome at their unique jobs.